Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant

Ann Hematol. 2021 Jun;100(6):1629-1630. doi: 10.1007/s00277-021-04408-z. Epub 2021 Jan 12.

Authors

Amany R Keruakous¹, Pragathi Balakrishna², Sarah A Schmidt², Marcus T Autry², Adam Asch²

Affiliations

¹ University of Oklahoma Health Sciences Center, Stephenson Cancer Center, 800 NE 10th street, Oklahoma City, OK, 73104, USA. [email protected].
² University of Oklahoma Health Sciences Center, Stephenson Cancer Center, 800 NE 10th street, Oklahoma City, OK, 73104, USA.

PMID: 33433650
DOI: 10.1007/s00277-021-04408-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Antineoplastic Agents / therapeutic use
Benzamides / therapeutic use
Female
Genomics
Humans
Leukemia, Hairy Cell / diagnosis
Leukemia, Hairy Cell / drug therapy
Leukemia, Hairy Cell / genetics*
Mutation* / drug effects
Pyrazines / therapeutic use

Substances

Antineoplastic Agents
Benzamides
Pyrazines
acalabrutinib